Details for New Drug Application (NDA): 215057
✉ Email this page to a colleague
The generic ingredient in NELARABINE is nelarabine. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the nelarabine profile page.
Summary for 215057
Tradename: | NELARABINE |
Applicant: | Nexus |
Ingredient: | nelarabine |
Patents: | 0 |
Pharmacology for NDA: 215057
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 250MG/50ML (5MG/ML) | ||||
Approval Date: | Jun 2, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription